Crossmark Global Holdings Inc. Purchases New Position in Addus HomeCare Co. (NASDAQ:ADUS)

Crossmark Global Holdings Inc. acquired a new position in Addus HomeCare Co. (NASDAQ:ADUS) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,712 shares of the company’s stock, valued at approximately $228,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Point72 Asset Management L.P. boosted its holdings in Addus HomeCare by 73.4% during the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock worth $86,598,000 after buying an additional 315,602 shares in the last quarter. Millennium Management LLC boosted its stake in shares of Addus HomeCare by 412.7% during the 2nd quarter. Millennium Management LLC now owns 316,418 shares of the company’s stock worth $36,739,000 after acquiring an additional 254,705 shares in the last quarter. Boston Partners acquired a new stake in shares of Addus HomeCare during the 1st quarter valued at about $12,215,000. Ghisallo Capital Management LLC purchased a new position in shares of Addus HomeCare in the 2nd quarter valued at about $11,611,000. Finally, Principal Financial Group Inc. raised its holdings in Addus HomeCare by 17.5% in the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after purchasing an additional 75,409 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now directly owns 7,215 shares in the company, valued at $961,687.35. The trade was a 75.23 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total transaction of $65,015.00. Following the sale, the director now owns 3,866 shares of the company’s stock, valued at $502,695.98. This represents a 11.45 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 22,917 shares of company stock worth $3,050,082 in the last three months. 4.60% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several analysts have commented on the company. Royal Bank of Canada reissued an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a report on Thursday, November 14th. Macquarie reissued an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a report on Monday, November 4th. Stephens upped their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 6th. Oppenheimer lifted their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. Finally, KeyCorp started coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They set an “overweight” rating and a $150.00 price target for the company. One equities research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $131.63.

Addus HomeCare Trading Down 1.3 %

NASDAQ:ADUS opened at $118.27 on Tuesday. Addus HomeCare Co. has a twelve month low of $85.43 and a twelve month high of $136.12. The company has a market cap of $2.14 billion, a P/E ratio of 27.06, a P/E/G ratio of 2.09 and a beta of 1.04. The company’s 50-day moving average price is $128.82 and its 200-day moving average price is $122.73.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $289.80 million for the quarter, compared to analysts’ expectations of $289.42 million. During the same period in the previous year, the firm posted $1.03 EPS. The business’s revenue for the quarter was up 7.1% compared to the same quarter last year. On average, analysts expect that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.